TOI Stock Price, Chart, Stats & News

The Oncology Institute, Inc.
Save
486.92M
Market cap
–
Current P/E
–
Forward P/E
TOI chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 13.82% |
Operating margin | -7.18% |
Pretax margin | -12.08% |
Net margin | -12.06% |
Effective tax rate | 0.22% |
ROA | -36.81% |
ROE | 759.71% |
D/E | -1.67x |
Interest coverage ratio | -3.20x |
TOI valuation
P/E | – |
P/S | 0.58x |
P/B | -191.04x |
P/CF | -122.14x |
P/FCF | -10.53x |
P/OCF | -122.14x |
PEG | -3.17x |
EV multiple | -10.29x |
About
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services.
Similar securities
Based on sector and market capitalization
Report issue











